Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Liquid Biopsy Market


6. Market Share Analysis – Global Liquid Biopsy Market

6.1 By Product
6.2 By Application

6.2.1 By Cancer Type

6.3 By Circulating Biomarker
6.4 By End Users
6.5 By Country


7. Product – Global Liquid Biopsy Market

7.1 Kits & Reagents
7.2 Platforms & Instruments
7.3 Services


8. Application – Global Liquid Biopsy Market

8.1 Cancer Therapeutic Application

8.1.1 By Cancer Type
8.1.1.1 Lung Cancer
8.1.1.2 Breast Cancer
8.1.1.3 Colorectal Cancer
8.1.1.4 Prostate Cancer
8.1.1.5 Liver Cancer
8.1.1.6 Other Cancers

8.2 Reproductive Health
8.3 Other Therapeutic


9. Circulating Biomarker – Global Liquid Biopsy Market

9.1 Circulating Tumor Cell
9.2 Circulating Tumor DNA
9.3 Cell-free DNA (cfDNA)
9.4 Extracellular Vesicles
9.5 Other Biomarkers


10. End User – Global Liquid Biopsy Market

10.1 Hospitals
10.2 Diagnostic Laboratories
10.3 Point-of-care Testing
10.4 Academic Institutes
10.5 Others


11. Country – Global Liquid Biopsy Market

11.1 Americas

11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.1.4 Brazil

11.2 Europe

11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands

11.3 Asia – Pacific

11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia

11.4 Middle East & Africa

11.4.1 United Arab Emirates
11.4.2 South Africa

11.5 Rest of the World


12. Porter’s Five Analysis – Global Liquid Biopsy Market

12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis – Global Liquid Biopsy Market

13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat


14. Company Analysis

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Financial Insight

14.2 Bio-Rad Laboratories

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Financial Insight

14.3 Thermo Fisher Scientific Inc.

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Financial Insight

14.4 Johnson & Johnson

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Financial Insight

14.5 Biocept Inc.

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Financial Insight

14.6 Guardant Health

14.6.1 Overview
14.6.2 Recent Development
14.6.3 Financial Insight

14.7 Illumina, Inc.

14.7.1 Overview
14.7.2 Recent Development
14.7.3 Financial Insight

14.8 Laboratory Corporation of America Holdings

14.8.1 Overview
14.8.2 Recent Development
14.8.3 Financial Insight

14.9 QIAGEN N.V

14.9.1 Overview
14.9.2 Recent Development
14.9.3 Financial Insight

14.10 Exact Sciences Corporation

14.10.1 Overview
14.10.2 Recent Development
14.10.3 Financial Insight



List of Figures

Figure-01: Global – Liquid Biopsy Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Liquid Biopsy Market (Billion US$), 2024 – 2030
Figure-03: Product – Kits & Reagents Market (Million US$), 2018 – 2023
Figure-04: Product – Forecast for Kits & Reagents Market (Million US$), 2024 – 2030
Figure-05: Product – Platforms & Instruments Market (Million US$), 2018 – 2023
Figure-06: Product – Forecast for Platforms & Instruments Market (Million US$), 2024 – 2030
Figure-07: Product – Services Market (Million US$), 2018 – 2023
Figure-08: Product – Forecast for Services Market (Million US$), 2024 – 2030
Figure-09: Application – Cancer Therapeutic Application Market (Million US$), 2018 – 2023
Figure-10: Application – Forecast for Cancer Therapeutic Application Market (Million US$), 2024 – 2030
Figure-11: Cancer Type – Lung Cancer Market (Million US$), 2018 – 2023
Figure-12: Cancer Type – Forecast for Lung Cancer Market (Million US$), 2024 – 2030
Figure-13: Cancer Type – Breast Cancer Market (Million US$), 2018 – 2023
Figure-14: Cancer Type – Forecast for Breast Cancer Market (Million US$), 2024 – 2030
Figure-15: Cancer Type – Colorectal Cancer Market (Million US$), 2018 – 2023
Figure-16: Cancer Type – Forecast for Colorectal Cancer Market (Million US$), 2024 – 2030
Figure-17: Cancer Type – Prostate Cancer Market (Million US$), 2018 – 2023
Figure-18: Cancer Type – Forecast for Prostate Cancer Market (Million US$), 2024 – 2030
Figure-19: Cancer Type – Liver Cancer Market (Million US$), 2018 – 2023
Figure-20: Cancer Type – Forecast for Liver Cancer Market (Million US$), 2024 – 2030
Figure-21: Cancer Type – Other Cancers Market (Million US$), 2018 – 2023
Figure-22: Cancer Type – Forecast for Other Cancers Market (Million US$), 2024 – 2030
Figure-23: Application – Reproductive Health Market (Million US$), 2018 – 2023
Figure-24: Application – Forecast for Reproductive Health Market (Million US$), 2024 – 2030
Figure-25: Application – Other Therapeutic Market (Million US$), 2018 – 2023
Figure-26: Application – Forecast for Other Therapeutic Market (Million US$), 2024 – 2030
Figure-27: Circulating Biomarker – Circulating Tumor Cell Market (Million US$), 2018 – 2023
Figure-28: Circulating Biomarker – Forecast for Circulating Tumor Cell Market (Million US$), 2024 – 2030
Figure-29: Circulating Biomarker – Circulating Tumor DNA Market (Million US$), 2018 – 2023
Figure-30: Circulating Biomarker – Forecast for Circulating Tumor DNA Market (Million US$), 2024 – 2030
Figure-31: Circulating Biomarker – Cell-free DNA (cfDNA) Market (Million US$), 2018 – 2023
Figure-32: Circulating Biomarker – Forecast for Cell-free DNA (cfDNA) Market (Million US$), 2024 – 2030
Figure-33: Circulating Biomarker – Extracellular Vesicles Market (Million US$), 2018 – 2023
Figure-34: Circulating Biomarker – Forecast for Extracellular Vesicles Market (Million US$), 2024 – 2030
Figure-35: Circulating Biomarker – Other Biomarkers Market (Million US$), 2018 – 2023
Figure-36: Circulating Biomarker – Forecast for Other Biomarkers Market (Million US$), 2024 – 2030
Figure-37: End User – Hospitals Market (Million US$), 2018 – 2023
Figure-38: End User – Forecast for Hospitals Market (Million US$), 2024 – 2030
Figure-39: End User – Diagnostic Laboratories Market (Million US$), 2018 – 2023
Figure-40: End User – Forecast for Diagnostic Laboratories Market (Million US$), 2024 – 2030
Figure-41: End User – Point-of-care Testing Market (Million US$), 2018 – 2023
Figure-42: End User – Forecast for Point-of-care Testing Market (Million US$), 2024 – 2030
Figure-43: End User – Academic Institutes Market (Million US$), 2018 – 2023
Figure-44: End User – Forecast for Academic Institutes Market (Million US$), 2024 – 2030
Figure-45: End User – Others Market (Million US$), 2018 – 2023
Figure-46: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-47: United States – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-48: United States – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-49: Canada – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-50: Canada – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-51: Mexico – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-52: Mexico – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-53: Brazil – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-54: Brazil – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-55: United Kingdom – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-56: United Kingdom – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-57: Germany – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-58: Germany – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-59: France – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-60: France – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-61: Italy – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-62: Italy – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-63: Spain – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-64: Spain – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-65: Netherlands – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-66: Netherlands – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-67: China – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-68: China – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-69: Japan – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-70: Japan – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-71: India – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-72: India – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-73: South Korea – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-74: South Korea – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-75: Australia – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-76: Australia – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-77: United Arab Emirates – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-78: United Arab Emirates – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-79: South Africa – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-80: South Africa – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-81: Rest of the World – Liquid Biopsy Market (Million US$), 2018 – 2023
Figure-82: Rest of the World – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-83: F. Hoffmann-La Roche Ltd. – Global Revenue (Million US$), 2018 – 2023
Figure-84: F. Hoffmann-La Roche Ltd. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-85: Bio-Rad Laboratories – Global Revenue (Million US$), 2018 – 2023
Figure-86: Bio-Rad Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-87: Thermo Fisher Scientific Inc. – Global Revenue (Million US$), 2018 – 2023
Figure-88: Thermo Fisher Scientific Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-89: Johnson & Johnson – Global Revenue (Million US$), 2018 – 2023
Figure-90: Johnson & Johnson – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-91: Biocept Inc. – Global Revenue (Million US$), 2018 – 2023
Figure-92: Biocept Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-93: Guardant Health – Global Revenue (Million US$), 2018 – 2023
Figure-94: Guardant Health – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-95: Illumina, Inc. – Global Revenue (Million US$), 2018 – 2023
Figure-96: Illumina, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-97: Laboratory Corporation of America Holdings – Global Revenue (Million US$), 2018 – 2023
Figure-98: Laboratory Corporation of America Holdings – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-99: QIAGEN N.V – Global Revenue (Million US$), 2018 – 2023
Figure-100: QIAGEN N.V – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-101: Exact Sciences Corporation – Global Revenue (Million US$), 2018 – 2023
Figure-102: Exact Sciences Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables

Table-01: Global – Liquid Biopsy Market Share by Product (Percent), 2018 – 2023
Table-02: Global – Forecast for Liquid Biopsy Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Liquid Biopsy Market Share by Application (Percent), 2018 – 2023
Table-04: Global – Forecast for Liquid Biopsy Market Share by Application (Percent), 2024 – 2030
Table-05: Global – Liquid Biopsy Market Share by Cancer Type (Percent), 2018 – 2023
Table-06: Global – Forecast for Liquid Biopsy Market Share by Cancer Type (Percent), 2024 – 2030
Table-07: Global – Liquid Biopsy Market Share by Circulating Biomarker (Percent), 2018 – 2023
Table-08: Global – Forecast for Liquid Biopsy Market Share by Circulating Biomarker (Percent), 2024 – 2030
Table-09: Global – Liquid Biopsy Market Share by End User (Percent), 2018 – 2023
Table-10: Global – Forecast for Liquid Biopsy Market Share by End User (Percent), 2024 – 2030
Table-11: Global – Liquid Biopsy Market Share by Countries (Percent), 2018 – 2023
Table-12: Global – Forecast for Liquid Biopsy Market Share by Countries (Percent), 2024 – 2030